Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
In Gaucher disease (GD), mutant β-glucocerebrosidases (β-GCase) that are misfolded are recognized by the quality control machinery of the endoplasmic reticulum (ER) and degraded proteolytically. Hydrophobic iminosugars can be used as pharmacological chaperones to provide an improvement in the foldin...
Principais autores: | Diot, J, Garcia Moreno, I, Twigg, G, Ortiz Mellet, C, Haupt, K, Butters, T, Kovensky, J, Gouin, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2011
|
Registros relacionados
-
Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
por: Wang, G, et al.
Publicado em: (2012) -
Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
por: Brumshtein, B, et al.
Publicado em: (2007) -
Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
por: Wang, G, et al.
Publicado em: (2009) -
Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.
por: Trapero, A, et al.
Publicado em: (2012) -
Gaucher disease.
por: Butters, T
Publicado em: (2007)